Author | Hasslocher-Moreno, Alejandro Marcel | |
Access date | 2022-10-16T13:49:11Z | |
Available date | 2022-10-16T13:49:11Z | |
Document date | 2022 | |
Citation | HASSLOCHER-MORENO, Alejandro Marcel. Re: "Immunothrombotic dysregulation in chagas disease and COVID 19: a comparative study of anticoagulation". Molecular and cellular biochemistry, v. 477, n. 4, p. 1093-1094, 2022 | en_US |
ISSN | 1573-4919 | en_US |
URI | https://www.arca.fiocruz.br/handle/icict/55165 | |
Language | eng | en_US |
Publisher | Springer | en_US |
Rights | open access | en_US |
Title | Re: Immunothrombotic dysregulation in chagas disease and COVID‑19 a comparative study of anticoagulation | en_US |
Type | Article | en_US |
DOI | 10.1007/s11010-022-04361-z | |
Abstract | The natural history of Chagas disease (CD) has two phases: acute and chronic.
Acute phase onset is near the moment of contamination.
In contrast, the chronic phase occurs after the regression
of the acute phase and has four well-defned clinical forms:
the indeterminate form (60%), in which the individual does
not show symptoms and signs of CD; the cardiac form
(25%), which frequently involves rhythm and/or conduction
heart disorders, left ventricular systolic dysfunction with or
without heart failure, and thromboembolic phenomena; the
digestive form (10%), which involves peristalsis dysfunction
of the esophagus and or intestine; and the mixed form (5%),
when cardiac and digestive manifestations occur simultane‑
ously. | en_US |
Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | en_US |
Subject | COVID-19 | en_US |
Subject | Immunothrombosis | en_US |
Subject | SARS-CoV-2 | en_US |
Subject | Chagas disease | en_US |